Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications

J Feng, X Wang, X Ye, I Ares, B Lopez-Torres… - Pharmacological …, 2022 - Elsevier
Metformin is the oldest and most commonly used first-line antidiabetic drug because of its
good clinical efficacy, high safety, low cost and easy access. At the same time, in recent …

New avenues for the treatment of Huntington's disease

A Kim, K Lalonde, A Truesdell, P Gomes Welter… - International journal of …, 2021 - mdpi.com
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in
the HD gene. The disease is characterized by neurodegeneration, particularly in the striatum …

[HTML][HTML] AMPK: potential therapeutic target for ischemic stroke

S Jiang, T Li, T Ji, W Yi, Z Yang, S Wang, Y Yang… - Theranostics, 2018 - ncbi.nlm.nih.gov
AMP-activated protein kinase (AMPK), a member of the serine/threonine (Ser/Thr) kinase
group, is universally distributed in various cells and organs. It is a significant endogenous …

Metformin: A review of potential mechanism and therapeutic utility beyond diabetes

S Dutta, RB Shah, S Singhal, SB Dutta… - Drug Design …, 2023 - Taylor & Francis
Metformin has been designated as one of the most crucial first-line therapeutic agents in the
management of type 2 diabetes mellitus. Primarily being an antihyperglycemic agent …

Metformin promotes microglial cells to facilitate myelin debris clearance and accelerate nerve repairment after spinal cord injury

Y Wu, J Xiong, Z He, Y Yuan, B Wang, J Xu… - Acta Pharmacologica …, 2022 - nature.com
Spinal cord injury (SCI) is one kind of severe trauma for central nervous system. Myelin
debris clearance and axon regeneration are essential for nerve regeneration after SCI …

Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system

S Demaré, A Kothari, NA Calcutt… - Expert review of …, 2021 - Taylor & Francis
Introduction: Metformin is currently first line therapy for type 2 diabetes (T2D). The
mechanism of action of metformin involves activation of AMP-activated protein kinase …

Metformin promotes axon regeneration after spinal cord injury through inhibiting oxidative stress and stabilizing microtubule

H Wang, Z Zheng, W Han, Y Yuan, Y Li… - Oxidative medicine …, 2020 - Wiley Online Library
Spinal cord injury (SCI) is a devastating disease that may lead to lifelong disability. Thus,
seeking for valid drugs that are beneficial to promoting axonal regrowth and elongation after …

SIRT3 regulation of mitochondrial quality control in neurodegenerative diseases

H Meng, WY Yan, YH Lei, Z Wan, YY Hou… - Frontiers in aging …, 2019 - frontiersin.org
Neurodegenerative diseases are disorders that are characterized by a progressive decline
of motor and/or cognitive functions caused by the selective degeneration and loss of …

Exploring the pharmacological potential of metformin for neurodegenerative diseases

MR Du, QY Gao, CL Liu, LY Bai, T Li… - Frontiers in Aging …, 2022 - frontiersin.org
Metformin, one of the first-line of hypoglycemic drugs, has cardioprotective, anti-
inflammatory and anticancer activities, in addition to its proven hypoglycemic effects …

Metformin improves functional recovery after spinal cord injury via autophagy flux stimulation

DI Zhang, J Xuan, B Zheng, Y Zhou, Y Lin, Y Wu… - Molecular …, 2017 - Springer
Spinal cord injury (SCI) is a severe neurological disease with few efficacious drugs.
Autophagy is a cellular process to confront with stress after SCI and considered to be a …